Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.

Sommariva M, Le Noci V, Bianchi F, Camelliti S, Balsari A, Tagliabue E, Sfondrini L.

Cell Mol Life Sci. 2020 Jan 23. doi: 10.1007/s00018-020-03452-8. [Epub ahead of print] Review.

PMID:
31974656
2.

Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94.

Caccuri F, Sommariva M, Marsico S, Giordano F, Zani A, Giacomini A, Fraefel C, Balsari A, Caruso A.

Cancers (Basel). 2019 Jul 18;11(7). pii: E1006. doi: 10.3390/cancers11071006.

3.

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases.

Le Noci V, Sommariva M, Bianchi F, Triulzi T, Tagliabue E, Balsari A, Sfondrini L.

J Immunol Res. 2019 Jun 20;2019:2015892. doi: 10.1155/2019/2015892. eCollection 2019.

4.

Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.

Fontana F, Raimondi M, Marzagalli M, Sommariva M, Limonta P, Gagliano N.

Cells. 2019 Feb 11;8(2). pii: E143. doi: 10.3390/cells8020143.

5.

Tumor⁻Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential.

Procacci P, Moscheni C, Sartori P, Sommariva M, Gagliano N.

Cells. 2018 Oct 5;7(10). pii: E158. doi: 10.3390/cells7100158.

6.

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases.

Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, Storti C, Triulzi T, Castelli C, Balsari A, Tagliabue E, Sfondrini L.

Cell Rep. 2018 Sep 25;24(13):3528-3538. doi: 10.1016/j.celrep.2018.08.090.

7.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC.

Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11.

8.

3D-spheroids: What can they tell us about pancreatic ductal adenocarcinoma cell phenotype?

Gagliano N, Sforza C, Sommariva M, Menon A, Conte V, Sartori P, Procacci P.

Exp Cell Res. 2017 Aug 15;357(2):299-309. doi: 10.1016/j.yexcr.2017.05.027. Epub 2017 May 29.

PMID:
28571915
9.

Three months of Western diet induces small intestinal mucosa alteration in TLR KO mice.

Sardi C, Luchini P, Emanuelli A, Giannoni A, Martini E, Manara LM, Sfondrini L, Kallikourdis M, Sommariva M, Rumio C.

Microsc Res Tech. 2017 Jun;80(6):563-569. doi: 10.1002/jemt.22831. Epub 2017 Jan 17.

PMID:
28094890
10.

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

Sommariva M, Le Noci V, Storti C, Bianchi F, Tagliabue E, Balsari A, Sfondrini L.

Cell Immunol. 2017 Mar;313:52-58. doi: 10.1016/j.cellimm.2017.01.004. Epub 2017 Jan 5.

PMID:
28089340
11.

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor.

Le Noci V, Sommariva M, Tortoreto M, Zaffaroni N, Campiglio M, Tagliabue E, Balsari A, Sfondrini L.

Oncoimmunology. 2016 Sep 20;5(11):e1234571. doi: 10.1080/2162402X.2016.1234571. eCollection 2016.

12.

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells.

Bianchi F, Sommariva M, De Cecco L, Triulzi T, Romero-Cordoba S, Tagliabue E, Sfondrini L, Balsari A.

Cell Cycle. 2016 Dec;15(23):3220-3229. Epub 2016 Oct 18.

13.

Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.

Sabatino M, Hu J, Sommariva M, Gautam S, Fellowes V, Hocker JD, Dougherty S, Qin H, Klebanoff CA, Fry TJ, Gress RE, Kochenderfer JN, Stroncek DF, Ji Y, Gattinoni L.

Blood. 2016 Jul 28;128(4):519-28. doi: 10.1182/blood-2015-11-683847. Epub 2016 May 25.

14.

Aerosol Delivery in the Treatment of Lung Cancer.

Storti C, Le Noci V, Sommariva M, Tagliabue E, Balsari A, Sfondrini L.

Curr Cancer Drug Targets. 2015;15(7):604-12. Review.

PMID:
26033086
15.

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus.

Ascierto ML, Bozzano F, Bedognetti D, Marras F, Schechterly C, Matsuura K, Picciotto A, Marenco S, Zhao Y, DeGiorgi V, Sommariva M, Moretta L, Wang E, Alter HJ, Marincola FM, De Maria A.

J Transl Med. 2015 Mar 1;13:77. doi: 10.1186/s12967-015-0428-x.

16.

The immune-related role of BRAF in melanoma.

Tomei S, Bedognetti D, De Giorgi V, Sommariva M, Civini S, Reinboth J, Al Hashmi M, Ascierto ML, Liu Q, Ayotte BD, Worschech A, Uccellini L, Ascierto PA, Stroncek D, Palmieri G, Chouchane L, Wang E, Marincola FM.

Mol Oncol. 2015 Jan;9(1):93-104. doi: 10.1016/j.molonc.2014.07.014. Epub 2014 Aug 6.

17.

Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.

Cardani D, Sardi C, La Ferla B, D'Orazio G, Sommariva M, Marcucci F, Olivero D, Tagliabue E, Koepsell H, Nicotra F, Balsari A, Rumio C.

Mol Cancer. 2014 Feb 5;13:23. doi: 10.1186/1476-4598-13-23.

18.

Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.

Pos Z, Spivey TL, Liu H, Sommariva M, Chen J, Wunderlich JR, Parisi G, Tomei S, Ayotte BD, Stroncek DF, Malek JA, Robbins PF, Rivoltini L, Maio M, Chouchane L, Wang E, Marincola FM.

J Invest Dermatol. 2014 May;134(5):1389-1396. doi: 10.1038/jid.2013.495. Epub 2013 Nov 22.

19.

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.

De Cecco L, Berardi M, Sommariva M, Cataldo A, Canevari S, Mezzanzanica D, Iorio MV, Tagliabue E, Balsari A.

PLoS One. 2013;8(3):e58849. doi: 10.1371/journal.pone.0058849. Epub 2013 Mar 6.

20.

High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors.

Sommariva M, de Cesare M, Meini A, Cataldo A, Zaffaroni N, Tagliabue E, Balsari A.

J Transl Med. 2013 Jan 29;11:25. doi: 10.1186/1479-5876-11-25.

Supplemental Content

Loading ...
Support Center